Skip to content

Dabigatran Etexilate

Dabigatran Etexilate (Pradaxa) is an anticoagulant used to prevent stroke and treat blood clots in the deep veins. This page lists the single formulation available in the catalogue.

Pradaxa

Stroke Prevention, Deep Vein Thrombosis

75mg · 110mg · 150mg

Dabigatran etexilate capsules to prevent stroke and treat deep vein thrombosis. It stops thrombin from forming blood clots.

From$2.57/ capsuleView

Key points

  • Dabigatran is a direct oral anticoagulant that works by blocking thrombin, a protein needed for blood clots to form.
  • The capsule comes in three strengths, 75 mg, 110 mg, and 150 mg, and the strength chosen depends on the condition being treated.
  • Pradaxa is the originator brand by Boehringer Ingelheim; it is the only listing in this catalogue.

What Dabigatran Etexilate is used for

Dabigatran Etexilate is listed for Stroke Prevention and for Deep Vein Thrombosis. It falls under the Blood Thinners category and is available in this catalogue as Pradaxa capsule, the originator brand by Boehringer Ingelheim.

Further reading